This is the dawn of the age of rejuvenation biotechnology, with a near future of widespread support for that goal. Seems to me like we're not that close to hav

This is the dawn of the age of rejuvenation biotechnology, with a near future of widespread support for that goal. Seems to me like we're not that close to having "widespread support" in the general public for tackling aging, so I'm curious to know why you think this will change in the near future. Is it just that attitudes will change once everyone realizes how close to reality it is, rather than crazy sci-fi? Isn't regulation also a problem here? That is, aging is not considered a disease in and of itself, making it difficult to authorize any human clinical trials? I thought it was necessary for SENS to piggy-back off of treatments for officially recognized diseases caused by aging. But I've been reading a book from 2007 about this stuff, so it's possible all that is completely out of date now. Edit: sorry missed your last bit about regulation. I suppose with big-pharma lobbying, that could be cleared up easily enough, given the profit potential you mention.